Experimental eye drops offered to patients with severe eye condition from bone marrow transplant
NCT ID NCT07210619
Summary
This program provides access to an investigational eye drop treatment called d-MAPPS™ for adults with severe chronic ocular graft-versus-host disease (oGVHD) who have no other good treatment options and cannot join clinical trials. The eye drops contain proteins that may help heal the eye surface in patients who developed this condition after a bone marrow transplant. The treatment is not yet FDA-approved, but eligible patients can request access through their eye doctor when standard treatments have failed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OGVHD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.